Cargando…
FGF6 promotes cardiac repair after myocardial infarction by inhibiting the Hippo pathway
OBJECTIVES: Myocardial infarction (MI) commonly occurs in patients with coronary artery disease and have high mortality. Current clinical strategies for MI still limited to reducing the death of myocardial cells but failed to replace these cells. This study aimed to investigate the role of fibroblas...
Autores principales: | Hu, Zhicheng, Chen, Peng, Wang, Linlin, Zhu, Yu, Chen, Gen, Chen, Yunjie, Hu, Zhenyu, Mei, Lin, You, Weijing, Cong, Weitao, Jin, Litai, Wang, Xu, Wang, Yang, Guan, Xueqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136516/ https://www.ncbi.nlm.nih.gov/pubmed/35355356 http://dx.doi.org/10.1111/cpr.13221 |
Ejemplares similares
-
Fibroblast growth factor 7 alleviates myocardial infarction by improving oxidative stress via PI3Kα/AKT-mediated regulation of Nrf2 and HXK2
por: Mei, Lin, et al.
Publicado: (2022) -
bFGF alleviates diabetes-associated endothelial impairment by downregulating inflammation via S-nitrosylation pathway
por: Chen, Gen, et al.
Publicado: (2021) -
Histone deacetylase 3 inhibition alleviates type 2 diabetes mellitus-induced endothelial dysfunction via Nrf2
por: Huang, Shuai, et al.
Publicado: (2021) -
Fibroblast growth factor 18 alleviates stress-induced pathological cardiac hypertrophy in male mice
por: Chen, Gen, et al.
Publicado: (2023) -
Fibroblast growth factor 20 attenuates pathological cardiac hypertrophy by activating the SIRT1 signaling pathway
por: Chen, Yunjie, et al.
Publicado: (2022)